FJZYY-1-fq-3012
This research article focuses on the use of clinical metagenomic next-generation sequencing technology for the diagnosis of febrile neutropenia in patients with acute leukemia. The study specifically examines the analysis of genetic material present in blood plasma samples, which can aid in identifying the cause of fever and low white blood cell count in these individuals. The authors demonstrate the effectiveness of this diagnostic approach through a series of experiments and provide evidence for its potential application in clinical settings. Overall, the study highlights the promising role of metagenomic next-generation sequencing in improving the accuracy and speed of diagnosis for febrile neutropenia in acute leukemia patients.